* see translation disclaimer below
|
|
Tell us what you think
|
|
Home
|
|
Demographics and Health Effects Key findings, Recommendations, Areas for further research, Slide kit
|
|
Efficacy Key findings, Recommendations, Areas for further research, Slide kit
|
|
Health Economics Key findings, Recommendations, Areas for further research, Slide kit
|
|
Policy Key findings, Recommendations, Areas for further research, Slide kit
|
|
Safety Key findings, Recommendations, Areas for further research, Slide kit
|
|
Electronic Cigarettes Key findings, Policy and Regulation, Areas for further research, Slide kit
|
|
Implementing Article 14
Resources to implement Article 14 on cessation
|
|
Resource library
|
|
Useful organisations
|
|
About Us
|
|
Funders
|
|
|
|

Areas for further research
- Development of pharmacotherapies based on a basic science understanding of the effects of nicotine and the nicotinic receptor.
- Development of more precise behavioural accounts of smoking that suggest more specific behavioural interventions.
- Identify elements of behavioural interventions that will enhance effectiveness.
- Find ways of enabling healthcare professionals to deliver routine opportunistic advice to stop smoking more often.
- Investigate the effectiveness of combining NRT and non-nicotine pharmacotherapies.
- Investigate the relative efficacy of NRT and varenicline.
- Investigate tailoring of pharmacotherapies to smoker characteristics.
- Investigate long-term use of pharmacotherapies to prevent relapse to smoking.
- Investigate effect of continuing pharmacological or behavioural treatment after a lapse to prevent relapse.
- Investigate use of NRT in pregnancy.
- Investigate whether use of NRT during temporary abstinence increases or decreases motivation to quit.
- Investigate long-term use of NRT or other pharmacotherapies as a harm reduction strategy to reduce the amount smoked.
- Investigate nicotine vaccines.
- Investigate sensory replacement via low-nicotine cigarettes and other methods.
- Develop and test interventions for adolescent smokers.
- Find ways of improving access to effective interventions.
- Identify organizational features of healthcare systems that support the delivery of appropriate interventions.
- Investigate repeated interventions for relapsers.
- Investigate treatment of smokers with co-morbidities (psychiatric illness, other chemical dependencies).
- Investigate proactive methods to prompt more smokers to make a quit attempt (e.g. phone calls or mailings).
- Investigate impact of healthcare reimbursement for smoking cessation intervention.
- Investigate use of smokeless tobacco as a treatment for smoking cessation.
|